1.
National Board of Osteopathic Medical
Examiners. COMAT clinical subject exams [Internet]. 2026 [cited 2026 Aug
4]. Available from: https://www.nbome.org/assessments/comat/clinical-subject-exams/
2.
National Board of Osteopathic Medical
Examiners. COMAT clinical–internal medicine: Core knowledge and elements
of osteopathic principles in the discipline of internal medicine
[Internet]. 2026 [cited 2026 Aug 4]. Available from: https://www.nbome.org/assessments/comat/clinical-subject-exams/internal-medicine/
3.
National Board of Osteopathic Medical
Examiners. Fundamental osteopathic medical competency domains 2026:
Guidelines for assessment for osteopathic medical licensure and the
distinctive practice of osteopathic medicine [Internet]. National Board
of Osteopathic Medical Examiners; 2026 [cited 2026 Aug 4]. Available
from: https://www.nbome.org/app/uploads/2026/01/FOMCD-2026_Web.pdf
4.
Creager MA, Barnes GD,
Giri J, et al. 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN
guideline for the evaluation and management of acute pulmonary embolism
in adults. Circulation. 2026;153(12). doi:10.1161/CIR.0000000000001415
5.
Rao SV, O’Donoghue ML,
Ruel M, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline for the
management of patients with acute coronary syndromes. Journal of the
American College of Cardiology. 2025;85(22):2135–237. doi:10.1016/j.jacc.2024.11.009
6.
Prabhakaran S, Gonzalez
NR, Zachrison KS, et al. 2026 guideline for the early management
of patients with acute ischemic stroke: A guideline from the american
heart association/american stroke association. Stroke. 2026;57(8).
doi:10.1161/STR.0000000000000513
7.
Greenberg SM, Ziai WC,
Cordonnier C, et al. 2022 guideline for the management of
patients with spontaneous intracerebral hemorrhage. Stroke.
2022;53(7):e282–361. doi:10.1161/STR.0000000000000407
8.
US
National Library of Medicine. DailyMed: Eliquis (apixaban) drug label
[Internet]. 2026 [cited 2026 Aug 4]. Available from: https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Eliquis
9.
Matthay MA, Arabi Y,
Arroliga AC, et al. A new global definition of acute respiratory
distress syndrome. American Journal of Respiratory and Critical Care
Medicine. 2024;209(1):37–47. doi:10.1164/rccm.202303-0558WS
10.
O’Driscoll BR, Howard LS, Earis J, Mak V.
British thoracic society guideline for oxygen use in adults in
healthcare and emergency settings. BMJ Open Respiratory Research.
2017;4(1):e000170. doi:10.1136/bmjresp-2016-000170
11.
Rochwerg B, Brochard L,
Elliott MW, et al. Official ERS/ATS clinical practice guidelines:
Noninvasive ventilation for acute respiratory failure. European
Respiratory Journal. 2017;50(2):1602426. doi:10.1183/13993003.02426-2016
12.
Qadir N, Sahetya S, Munshi
L, et al. An update on management of adult patients with acute
respiratory distress syndrome: An official american thoracic society
clinical practice guideline. American Journal of Respiratory and
Critical Care Medicine. 2024;209(1):24–36. doi:10.1164/rccm.202311-2011ST
13.
Golden DBK, Wang J,
Waserman S, et al. Anaphylaxis: A 2023 practice parameter update.
Annals of Allergy, Asthma and Immunology. 2024;132(2):124–76. doi:10.1016/j.anai.2023.09.015
14.
Laine L, Barkun AN,
Saltzman JR, et al. ACG clinical guideline: Upper
gastrointestinal and ulcer bleeding. American Journal of
Gastroenterology. 2021;116(5):899–917. doi:10.14309/ajg.0000000000001245
15.
Sengupta N, Feuerstein JD,
Jairath V, et al. Management of patients with acute lower
gastrointestinal bleeding: An updated ACG guideline. American Journal of
Gastroenterology. 2023;118(2):208–31. doi:10.14309/ajg.0000000000002130
16.
Kaplan DE, Ripoll C,
Thiele M, et al. AASLD practice guidance on risk stratification
and management of portal hypertension and varices in cirrhosis.
Hepatology. 2024;79(5):1180–211. doi:10.1097/HEP.0000000000000647
17.
Singer M, Deutschman CS,
Seymour CW, et al. The third international consensus definitions
for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–10. doi:10.1001/jama.2016.0287
18.
Evans L, Rhodes A,
Alhazzani W, et al. Surviving sepsis campaign: International
guidelines for management of sepsis and septic shock 2021. Intensive
Care Medicine. 2021;47:1181–247. doi:10.1007/s00134-021-06506-y
19.
UK
Kidney Association. Clinical practice guideline: Treatment of acute
hyperkalaemia in adults [Internet]. 2023 [cited 2026 Aug 4]. Available
from: https://guidelines.ukkidney.org/hyperkalaemia/
20.
Spasovski G, Vanholder R,
Allolio B, et al. Clinical practice guideline on diagnosis and
treatment of hyponatraemia. European Journal of Endocrinology.
2014;170(3):G1–47. doi:10.1530/EJE-13-1020
21.
Verbalis JG, Goldsmith SR,
Greenberg A, et al. Diagnosis, evaluation, and treatment of
hyponatremia: Expert panel recommendations. American Journal of
Medicine. 2013;126(10 Suppl 1):S1–42. doi:10.1016/j.amjmed.2013.07.006
22.
Umpierrez GE, Davis GM,
ElSayed NA, et al. Hyperglycemic crises in adults with diabetes:
A consensus report. Diabetes Care. 2024;47(8):1257–75. doi:10.2337/dci24-0032
23.
Wigginton JG, Agarwal S,
Bartos JA, et al. Part 9: Adult advanced life support: 2025
american heart association guidelines for cardiopulmonary resuscitation
and emergency cardiovascular care. Circulation. 2025;152(16 suppl
2):S538–77. doi:10.1161/CIR.0000000000001376
24.
US
Preventive Services Task Force. Breast cancer: screening [Internet].
2024 [cited 2026 Aug 4]. Available from: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening
25.
National Comprehensive Cancer Network. NCCN
clinical practice guidelines in oncology: Breast cancer screening and
diagnosis, version 1.2026 [Internet]. 2026 [cited 2026 Aug 4]. Available
from: https://www.nccn.org/professionals/physician_gls/pdf/breast-screening.pdf
26.
US
Preventive Services Task Force. Cervical cancer: screening [Internet].
2025 [cited 2026 Aug 4]. Available from: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-for-cervical-cancer
27.
US
Preventive Services Task Force. Lung cancer: screening [Internet]. 2021
[cited 2026 Aug 4]. Available from: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening
28.
US
Preventive Services Task Force. Abdominal aortic aneurysm: screening
[Internet]. 2019 [cited 2026 Aug 4]. Available from: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/abdominal-aortic-aneurysm-screening
29.
US
Preventive Services Task Force. BRCA-related cancer: Risk assessment,
genetic counseling, and genetic testing [Internet]. 2019 [cited 2026 Aug
4]. Available from: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing
30.
US
Preventive Services Task Force. Colorectal cancer: screening [Internet].
2021 [cited 2026 Aug 4]. Available from: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening
31.
Shaukat A, Kahi CJ, Burke
CA, et al. ACG clinical guidelines: Colorectal cancer screening
2021. American Journal of Gastroenterology. 2021;116(3):458–79. doi:10.14309/ajg.0000000000001122
32.
US
Preventive Services Task Force. Cervical cancer: screening [Internet].
2018 [cited 2026 Aug 4]. Available from: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening
33.
Perkins RB, Guido RS,
Castle PE, et al. 2019 ASCCP risk-based management consensus
guidelines for abnormal cervical cancer screening tests and cancer
precursors. Journal of Lower Genital Tract Disease. 2020;24(2):102–31.
doi:10.1097/LGT.0000000000000525
34.
US
Preventive Services Task Force. Osteoporosis to prevent fractures:
screening [Internet]. 2025 [cited 2026 Aug 4]. Available from: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening
35.
LeBoff MS, Greenspan SL,
Insogna KL, et al. The clinician’s guide to prevention and
treatment of osteoporosis. Osteoporosis International.
2022;33(10):2049–102. doi:10.1007/s00198-021-05900-y
36.
US
Preventive Services Task Force. Human immunodeficiency virus infection:
screening [Internet]. 2019 [cited 2026 Aug 4]. Available from: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening
37.
Centers for Disease Control and Prevention.
Clinical testing guidance for HIV [Internet]. 2024 [cited 2026 Aug 4].
Available from: https://www.cdc.gov/hivnexus/hcp/diagnosis-testing/index.html
38.
Centers for Disease Control and Prevention,
Association of Public Health Laboratories. 2018 quick reference guide:
Recommended laboratory HIV testing algorithm for serum or plasma
specimens [Internet]. Centers for Disease Control; Prevention; 2018
[cited 2026 Aug 4]. Available from: https://stacks.cdc.gov/view/cdc/50872
39.
US
Preventive Services Task Force. Hepatitis c virus infection in
adolescents and adults: screening [Internet]. 2020 [cited 2026 Aug 4].
Available from: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-for-hepatitis-c-virus-infection-in-adults
40.
US
Preventive Services Task Force. Hypertension in adults: screening
[Internet]. 2021 [cited 2026 Aug 4]. Available from: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hypertension-in-adults-screening
41.
Jones DW, Ferdinand KC,
Taler SJ, et al. 2025
AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM guideline for
the prevention, detection, evaluation, and management of high blood
pressure in adults. Journal of the American College of Cardiology.
2025;86(18):1567–678. doi:10.1016/j.jacc.2025.05.007
42.
US
Preventive Services Task Force. Prediabetes and type 2 diabetes:
screening [Internet]. 2021 [cited 2026 Aug 4]. Available from: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-for-prediabetes-and-type-2-diabetes
43.
US
Preventive Services Task Force. Statin use for the primary prevention of
cardiovascular disease in adults: Preventive medication [Internet]. 2022
[cited 2026 Aug 4]. Available from: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/statin-use-in-adults-preventive-medication
44.
Tanner MR, O’Shea JG, Byrd
KM, et al. Antiretroviral postexposure prophylaxis after sexual,
injection drug use, or other nonoccupational exposure to HIV—CDC
recommendations, united states, 2025. MMWR Recommendations and Reports.
2025;74(1):1–56. doi:10.15585/mmwr.rr7401a1
45.
Blumenthal RS, Morris PB,
Gaudino M, et al. 2026
ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the
management of dyslipidemia. Circulation. 2026;153(17). doi:10.1161/CIR.0000000000001423
46.
Centers for Disease Control and Prevention.
Adult immunization schedule addendum: Recommendations for ages 19 years
or older, united states, 2025 [Internet]. 2025 [cited 2026 Aug 4].
Available from: https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-addendum.html
47.
2023 American Geriatrics Society Beers Criteria
Update Expert Panel. American geriatrics society 2023 updated AGS beers
criteria for potentially inappropriate medication use in older adults.
Journal of the American Geriatrics Society. 2023;71(7):2052–81. doi:10.1111/jgs.18372
48.
Ross DS, Burch HB, Cooper
DS, et al. 2016 american thyroid association guidelines for
diagnosis and management of hyperthyroidism and other causes of
thyrotoxicosis. Thyroid. 2016;26(10):1343–421. doi:10.1089/thy.2016.0229
49.
Bornstein SR, Allolio B,
Arlt W, et al. Diagnosis and treatment of primary adrenal
insufficiency: An endocrine society clinical practice guideline. Journal
of Clinical Endocrinology and Metabolism. 2016;101(2):364–89. doi:10.1210/jc.2015-1710
50.
American Diabetes Association Professional
Practice Committee. 2. Diagnosis and classification of diabetes:
Standards of care in diabetes–2026. Diabetes Care. 2026;49(Supplement
1). doi:10.2337/dc26-S002
51.
American Diabetes Association Professional
Practice Committee. 3. Prevention or delay of diabetes and associated
comorbidities: Standards of care in diabetes–2026. Diabetes Care.
2026;49(Supplement 1). doi:10.2337/dc26-S003
52.
American Diabetes Association Professional
Practice Committee. 9. Pharmacologic approaches to glycemic treatment:
Standards of care in diabetes–2026. Diabetes Care. 2026;49(Supplement
1). doi:10.2337/dc26-S009
53.
Ndumele CE, Rodriguez F,
Dixon DL, et al. 2026 AHA/ACC/ADA/ASN guideline for the
prevention, detection, evaluation, and management of
cardiovascular-kidney-metabolic syndrome. Journal of the American
College of Cardiology. 2026;87(22):e1889–2007. doi:10.1016/j.jacc.2026.03.056
54.
Jonklaas J, Bianco AC,
Bauer AJ, et al. Guidelines for the treatment of hypothyroidism:
Prepared by the american thyroid association task force on thyroid
hormone replacement. Thyroid. 2014;24(12):1670–751. doi:10.1089/thy.2014.0028
55.
Bilezikian JP, Khan AA,
Silverberg SJ, et al. Evaluation and management of primary
hyperparathyroidism: Summary statement and guidelines from the fifth
international workshop. Journal of Bone and Mineral Research.
2022;37(11):2293–314. doi:10.1002/jbmr.4677
56.
El-Hajj Fuleihan G, Clines
GA, Hu MI, et al. Treatment of hypercalcemia of malignancy in
adults: An endocrine society clinical practice guideline. Journal of
Clinical Endocrinology and Metabolism. 2023;108(3):507–28. doi:10.1210/clinem/dgac621
57.
Turner J, Gittoes N, Selby
P, et al. Society for endocrinology endocrine emergency guidance:
Emergency management of acute hypocalcaemia in adult patients. Endocrine
Connections. 2016;5(5):G7–8. doi:10.1530/EC-16-0056
58.
Nieman LK, Biller BMK,
Findling JW, et al. The diagnosis of cushing’s syndrome: An
endocrine society clinical practice guideline. Journal of Clinical
Endocrinology and Metabolism. 2008;93(5):1526–40. doi:10.1210/jc.2008-0125
59.
Lenders JWM, Duh QY,
Eisenhofer G, et al. Pheochromocytoma and paraganglioma: An
endocrine society clinical practice guideline. Journal of Clinical
Endocrinology and Metabolism. 2014;99(6):1915–42. doi:10.1210/jc.2014-1498
60.
Nieman LK, Biller BMK,
Findling JW, et al. Treatment of cushing’s syndrome: An endocrine
society clinical practice guideline. Journal of Clinical Endocrinology
and Metabolism. 2015;100(8):2807–31. doi:10.1210/jc.2015-1818
61.
Melmed S, Casanueva FF,
Hoffman AR, et al. Diagnosis and treatment of hyperprolactinemia:
An endocrine society clinical practice guideline. Journal of Clinical
Endocrinology and Metabolism. 2011;96(2):273–88. doi:10.1210/jc.2010-1692
62.
Katznelson L, Laws ERJr,
Melmed S, et al. Acromegaly: An endocrine society clinical
practice guideline. Journal of Clinical Endocrinology and Metabolism.
2014;99(11):3933–51. doi:10.1210/jc.2014-2700
63.
Rajasekaran S, Vanderpump
M, Baldeweg S, et al. UK guidelines for the management of
pituitary apoplexy. Clinical Endocrinology. 2011;74(1):9–20. doi:10.1111/j.1365-2265.2010.03913.x
64.
Tomkins M, Lawless S,
Martin-Grace J, et al. Diagnosis and management of central
diabetes insipidus in adults. Journal of Clinical Endocrinology and
Metabolism. 2022;107(10):2701–15. doi:10.1210/clinem/dgac381
65.
Baldeweg SE, Ball S,
Brooke A, et al. Society for endocrinology clinical guidance:
Inpatient management of cranial diabetes insipidus. Endocrine
Connections. 2018;7(7):G8–11. doi:10.1530/EC-18-0154
66.
Glauser T, Shinnar S,
Gloss D, et al. Evidence-based guideline: Treatment of convulsive
status epilepticus in children and adults. Epilepsy Currents.
2016;16(1):48–61. doi:10.5698/1535-7597-16.1.48
67.
Devlin JW, Skrobik Y,
Gelinas C, et al. Clinical practice guidelines for the prevention
and management of pain, agitation/sedation, delirium, immobility, and
sleep disruption in adult patients in the ICU. Critical Care Medicine.
2018;46(9):e825–73. doi:10.1097/CCM.0000000000003299
68.
Kleindorfer DO, Towfighi
A, Chaturvedi S, et al. 2021 guideline for the prevention of
stroke in patients with stroke and transient ischemic attack. Stroke.
2021;52(7):e364–467. doi:10.1161/STR.0000000000000375
69.
Fisher RS, Acevedo C,
Arzimanoglou A, et al. ILAE official report: A practical clinical
definition of epilepsy. Epilepsia. 2014;55(4):475–82. doi:10.1111/epi.12550
70.
Krumholz A, Wiebe S,
Gronseth G, et al. Evidence-based guideline: Management of an
unprovoked first seizure in adults. Neurology. 2015;84(16):1705–13.
doi:10.1212/WNL.0000000000001487
71.
Kapur J, Elm J,
Chamberlain JM, et al. Randomized trial of three anticonvulsant
medications for status epilepticus. New England Journal of Medicine.
2019;381(22):2103–13. doi:10.1056/NEJMoa1905795
72.
Inouye SK, Dyck CH van,
Alessi CA, et al. Clarifying confusion: The confusion assessment
method. Annals of Internal Medicine. 1990;113(12):941–8. doi:10.7326/0003-4819-113-12-941
73.
McKhann GM, Knopman DS,
Chertkow H, et al. The diagnosis of dementia due to alzheimer’s
disease: Recommendations from the national institute on
aging–alzheimer’s association workgroups. Alzheimer’s and Dementia.
2011;7(3):263–9. doi:10.1016/j.jalz.2011.03.005
74.
Petersen RC, Lopez O,
Armstrong MJ, et al. Practice guideline update summary: Mild
cognitive impairment. Neurology. 2018;90(3):126–35. doi:10.1212/WNL.0000000000004826
75.
US
National Library of Medicine. DailyMed: Donepezil hydrochloride drug
labels [Internet]. 2026 [cited 2026 Aug 4]. Available from: https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=donepezil
76.
US
National Library of Medicine. DailyMed: Memantine hydrochloride drug
labels [Internet]. 2026 [cited 2026 Aug 4]. Available from: https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=memantine
77.
Doorn PA van, Van den
Bergh PYK, Hadden RDM, et al. European academy of
neurology/peripheral nerve society guideline on diagnosis and treatment
of guillain–barré syndrome. European Journal of Neurology.
2023;30(12):3646–74. doi:10.1111/ene.16073
78.
Narayanaswami P, Sanders
DB, Wolfe GI, et al. International consensus guidance for
management of myasthenia gravis: 2020 update. Neurology.
2021;96(3):114–22. doi:10.1212/WNL.0000000000011124
79.
National Institute for Health and Care
Excellence. Spinal metastases and metastatic spinal cord compression
[Internet]. 2023 [cited 2026 Aug 4]. Available from: https://www.nice.org.uk/guidance/ng234
80.
Price R, Smith AG,
Franklin G, et al. Oral and topical treatment of painful diabetic
polyneuropathy: Practice guideline update summary. Neurology.
2022;98(1):31–43. doi:10.1212/WNL.0000000000013038
81.
American Psychiatric Association. Diagnostic
and statistical manual of mental disorders: DSM-5-TR. 5th ed. American
Psychiatric Association Publishing; 2022. doi:10.1176/appi.books.9780890425787
82.
US
Department of Veterans Affairs and Department of Defense. VA/DoD
clinical practice guideline for assessment and management of patients at
risk for suicide [Internet]. 2024 [cited 2026 Aug 4]. Available from: https://www.healthquality.va.gov/guidelines/MH/srb/
83.
US
Department of Veterans Affairs and Department of Defense. VA/DoD
clinical practice guideline for the management of major depressive
disorder [Internet]. 2022 [cited 2026 Aug 4]. Available from: https://www.healthquality.va.gov/guidelines/MH/mdd/
84.
US
National Library of Medicine. DailyMed: Sertraline hydrochloride drug
labels [Internet]. 2026 [cited 2026 Aug 4]. Available from: https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=sertraline
85.
Yatham LN, Kennedy SH,
Parikh SV, et al. Canadian network for mood and anxiety
treatments and international society for bipolar disorders 2018
guidelines for the management of patients with bipolar disorder. Bipolar
Disorders. 2018;20(2):97–170. doi:10.1111/bdi.12609
86.
US
National Library of Medicine. DailyMed: Lithium and lithium carbonate
drug labels [Internet]. 2026 [cited 2026 Aug 4]. Available from: https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=lithium%20carbonate
87.
Maz M, Chung SA, Abril A,
et al. 2021 american college of rheumatology/vasculitis
foundation guideline for the management of giant cell arteritis and
takayasu arteritis. Arthritis and Rheumatology. 2021;73(8):1349–65.
doi:10.1002/art.41774
88.
Fraenkel L, Bathon JM,
England BR, et al. 2021 american college of rheumatology
guideline for the treatment of rheumatoid arthritis. Arthritis Care and
Research. 2021;73(7):924–39. doi:10.1002/acr.24596
89.
FitzGerald JD, Dalbeth N,
Mikuls T, et al. 2020 american college of rheumatology guideline
for the management of gout. Arthritis Care and Research.
2020;72(6):744–60. doi:10.1002/acr.24180
90.
American College of Rheumatology. 2025 american
college of rheumatology guideline for the treatment of systemic lupus
erythematosus [Internet]. 2025 [cited 2026 Aug 4]. Available from: https://rheumatology.org/lupus-guideline
91.
Ravn C, Neyt J, Benito N,
et al. Guideline for management of septic arthritis in native
joints (SANJO). Journal of Bone and Joint Infection. 2023;8:29–37.
doi:10.5194/jbji-8-29-2023
92.
Workowski KA, Bachmann LH,
Chan PA, et al. Sexually transmitted infections treatment
guidelines, 2021. MMWR Recommendations and Reports. 2021;70(4):1–187.
doi:10.15585/mmwr.rr7004a1
93.
Zhang W, Doherty M,
Pascual E, et al. EULAR recommendations for calcium pyrophosphate
deposition. Part II: management. Annals of the Rheumatic Diseases.
2011;70(4):571–5. doi:10.1136/ard.2010.139360
94.
Aletaha D, Neogi T, Silman
AJ, et al. 2010 rheumatoid arthritis classification criteria: An
american college of rheumatology/european league against rheumatism
collaborative initiative. Arthritis and Rheumatism. 2010;62(9):2569–81.
doi:10.1002/art.27584
95.
Aringer M, Costenbader K,
Daikh D, et al. 2019 european league against rheumatism/american
college of rheumatology classification criteria for systemic lupus
erythematosus. Arthritis and Rheumatology. 2019;71(9):1400–12. doi:10.1002/art.40930
96.
American College of Rheumatology. 2024 american
college of rheumatology guideline for the screening, treatment, and
management of lupus nephritis [Internet]. 2024 [cited 2026 Aug 4].
Available from: https://rheumatology.org/lupus-guideline
97.
Dasgupta B, Cimmino MA,
Maradit-Kremers H, et al. 2012 provisional classification
criteria for polymyalgia rheumatica: A european league against
rheumatism/american college of rheumatology collaborative initiative.
Annals of the Rheumatic Diseases. 2012;71(4):484–92. doi:10.1136/annrheumdis-2011-200329
98.
Dejaco C, Singh YP, Perel
P, et al. 2015 recommendations for the management of polymyalgia
rheumatica: A european league against rheumatism/american college of
rheumatology collaborative initiative. Annals of the Rheumatic Diseases.
2015;74(10):1799–807. doi:10.1136/annrheumdis-2015-207492
99.
Chung SA, Langford CA, Maz
M, et al. 2021 american college of rheumatology/vasculitis
foundation guideline for the management of antineutrophil cytoplasmic
antibody–associated vasculitis. Arthritis and Rheumatology.
2021;73(8):1366–83. doi:10.1002/art.41773
100.
Chung SA, Gorelik M,
Langford CA, et al. 2021 american college of
rheumatology/vasculitis foundation guideline for the management of
polyarteritis nodosa. Arthritis and Rheumatology. 2021;73(8):1384–93.
doi:10.1002/art.41776
101.
US
Food and Drug Administration. FDA adds boxed warning for increased risk
of severe hypocalcemia in patients with advanced chronic kidney disease
taking prolia (denosumab) [Internet]. 2024 [cited 2026 Aug 4]. Available
from: https://www.fda.gov/drugs/drug-safety-communications/fda-adds-boxed-warning-increased-risk-severe-hypocalcemia-patients-advanced-chronic-kidney-disease
102.
Humphrey MB, Russell L,
Danila MI, et al. 2022 american college of rheumatology guideline
for the prevention and treatment of glucocorticoid-induced osteoporosis.
Arthritis and Rheumatology. 2023;75(12):2088–102. doi:10.1002/art.42646
103.
Rudwaleit M, Heijde D van
der, Landewé R, et al. The development of assessment of
SpondyloArthritis international society classification criteria for
axial spondyloarthritis (part II): Validation and final selection.
Annals of the Rheumatic Diseases. 2009;68(6):777–83. doi:10.1136/ard.2009.108233
104.
Ramiro S, Nikiphorou E,
Sepriano A, et al. ASAS–EULAR recommendations for the management
of axial spondyloarthritis: 2022 update. Annals of the Rheumatic
Diseases. 2023;82(1):19–34. doi:10.1136/ard-2022-223296
105.
Low Back Pain Clinical Practice Guidelines TF
on the. American osteopathic association guidelines for osteopathic
manipulative treatment for patients with low back pain. Journal of the
American Osteopathic Association. 2016;116(8):536–49. doi:10.7556/jaoa.2016.107
106.
Kidney Disease: Improving Global Outcomes Acute
Kidney Injury Work Group. KDIGO clinical practice guideline for acute
kidney injury [Internet]. Kidney Disease: Improving Global Outcomes;
2012 [cited 2026 Aug 4]. Available from: https://kdigo.org/guidelines/acute-kidney-injury/
107.
Kidney Disease: Improving Global Outcomes CKD
Work Group. KDIGO 2024 clinical practice guideline for the evaluation
and management of chronic kidney disease. Kidney International.
2024;105(4S):S117–314. doi:10.1016/j.kint.2023.10.018
108.
Sterns RH. Evidence for managing hypernatremia:
Is it just hyponatremia in reverse? Clinical Journal of the American
Society of Nephrology. 2019;14(5):645–7. doi:10.2215/CJN.02950319
109.
Adrogué HJ, Madias NE. Management of
life-threatening acid-base disorders. First of two parts. New England
Journal of Medicine. 1998;338(1):26–34. doi:10.1056/NEJM199801013380106
110.
Do
C, Vasquez PC, Soleimani M. Metabolic alkalosis pathogenesis, diagnosis,
and treatment: Core curriculum 2022. American Journal of Kidney
Diseases. 2022;80(4):536–51. doi:10.1053/j.ajkd.2021.12.016
111.
Kidney Disease: Improving Global Outcomes
Glomerular Diseases Work Group. KDIGO 2021 clinical practice guideline
for the management of glomerular diseases. Kidney International.
2021;100(4S):S1–276. doi:10.1016/j.kint.2021.05.021
112.
Kobashi KC, Vasavada S,
Bloschichak A, et al. Updates to surgical treatment of female
stress urinary incontinence (SUI): AUA/SUFU guideline (2023). Journal of
Urology. 2023. doi:10.1097/JU.0000000000003435
113.
Cameron AP, Chung DE,
Dielubanza EJ, et al. The AUA/SUFU guideline on the diagnosis and
treatment of idiopathic overactive bladder. Journal of Urology. 2024.
doi:10.1097/JU.0000000000003985
114.
Serlin DC, Heidelbaugh JJ, Stoffel JT. Urinary
retention in adults: Evaluation and initial management. American Family
Physician [Internet]. 2018 [cited 2026 Aug 4];98(8):496–503. Available
from: https://www.aafp.org/afp/2018/1015/p496
115.
Stoffel JT, Peterson AC,
Sandhu JS, et al. AUA white paper on nonneurogenic chronic
urinary retention: Consensus definition, treatment algorithm, and
outcome end points. Journal of Urology. 2017;198(1):153–60. doi:10.1016/j.juro.2017.01.075
116.
Sandhu JS, Bixler BR, Dahm
P, et al. Management of lower urinary tract symptoms attributed
to benign prostatic hyperplasia (BPH): AUA guideline amendment 2023.
Journal of Urology. 2024. doi:10.1097/JU.0000000000003698
117.
Barocas DA, Lotan Y,
Matulewicz RS, et al. Updates to microhematuria: AUA/SUFU
guideline (2025). Journal of Urology. 2025. doi:10.1097/JU.0000000000004490
118.
Infectious Diseases Society of America. IDSA
2025 guideline update on complicated urinary tract infections
[Internet]. 2025 [cited 2026 Aug 4]. Available from: https://www.idsociety.org/practice-guideline/complicated-urinary-tract-infections/
119.
American Urological Association. Kidney stones:
Surgical management guideline [Internet]. 2022 [cited 2026 Aug 4].
Available from: https://www.auanet.org/guidelines-and-quality/guidelines/kidney-stones-surgical-management-guideline
120.
Gupta K, Hooton TM, Naber
KG, et al. International clinical practice guidelines for the
treatment of acute uncomplicated cystitis and pyelonephritis in women: A
2010 update by the infectious diseases society of america and the
european society for microbiology and infectious diseases. Clinical
Infectious Diseases. 2011;52(5):e103–20. doi:10.1093/cid/ciq257
121.
European Association of Urology. EAU guidelines
on urolithiasis [Internet]. 2025 [cited 2026 Aug 4]. Available from: https://uroweb.org/guidelines/urolithiasis
122.
American College of Obstetricians and
Gynecologists. Management of acute abnormal uterine bleeding in
nonpregnant reproductive-aged women [Internet]. 2013 [cited 2026 Aug 4].
Available from: https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2013/04/management-of-acute-abnormal-uterine-bleeding-in-nonpregnant-reproductive-aged-women
123.
American College of Obstetricians and
Gynecologists. Updated guidance regarding the role of transvaginal
ultrasonography in evaluating the endometrium of individuals with
postmenopausal bleeding. Obstetrics and Gynecology. 2026. doi:10.1097/AOG.0000000000006275
124.
American Urological Association. Medical
student curriculum: Acute scrotum [Internet]. 2025 [cited 2026 Aug 4].
Available from: https://www.auanet.org/meetings-and-education/for-medical-students/medical-students-curriculum/acute-scrotum
125.
American College of Obstetricians and
Gynecologists. ACOG practice bulletin no. 193: Tubal ectopic pregnancy.
Obstetrics and Gynecology. 2018;131(3):e91–103. doi:10.1097/AOG.0000000000002560
126.
Tenner S, Vege SS, Sheth
SG, et al. American college of gastroenterology guidelines:
Management of acute pancreatitis. American Journal of Gastroenterology.
2024;119(3):419–37. doi:10.14309/ajg.0000000000002645
127.
Biggins SW, Angeli P,
Garcia-Tsao G, et al. Diagnosis, evaluation, and management of
ascites, spontaneous bacterial peritonitis and hepatorenal syndrome.
Hepatology. 2021;74(2):1014–48. doi:10.1002/hep.31884
128.
Bajaj JS, Jakab SS,
Jesudian AB, et al. ACG clinical guideline: Hepatic
encephalopathy. American Journal of Gastroenterology.
2026;121(3):588–618. doi:10.14309/ajg.0000000000003899
129.
Katz PO, Dunbar KB,
Schnoll-Sussman FH, et al. ACG clinical guideline for the
diagnosis and management of gastroesophageal reflux disease. American
Journal of Gastroenterology. 2022;117(1):27–56. doi:10.14309/ajg.0000000000001538
130.
Chey WD, Howden CW, Moss
SF, et al. ACG clinical guideline: Treatment of helicobacter
pylori infection. American Journal of Gastroenterology.
2024;119(9):1730–53. doi:10.14309/ajg.0000000000002968
131.
Di Saverio S, Podda M, De
Simone B, et al. Diagnosis and treatment of acute appendicitis:
2020 update of the WSES jerusalem guidelines. World Journal of Emergency
Surgery. 2020;15:27. doi:10.1186/s13017-020-00306-3
132.
Bala M, Catena F, Kashuk
J, et al. Acute mesenteric ischemia: Updated guidelines of the
world society of emergency surgery. World Journal of Emergency Surgery.
2022;17:54. doi:10.1186/s13017-022-00443-x
133.
Shane AL, Mody RK, Crump
JA, et al. 2017 infectious diseases society of america clinical
practice guidelines for the diagnosis and management of infectious
diarrhea. Clinical Infectious Diseases. 2017;65(12):e45–80. doi:10.1093/cid/cix669
134.
Johnson S, Lavergne V,
Skinner AM, et al. Clinical practice guideline by the infectious
diseases society of america and society for healthcare epidemiology of
america: 2021 focused update guidelines on management of clostridioides
difficile infection in adults. Clinical Infectious Diseases.
2021;73(5):e1029–44. doi:10.1093/cid/ciab549
135.
Peery AF et al. ACG
clinical guideline: Management of colonic diverticulitis. American
Journal of Gastroenterology. 2026. doi:10.14309/ajg.0000000000004047
136.
Rubin DT, Ananthakrishnan
AN, Siegel CA, et al. ACG clinical guideline update: Ulcerative
colitis in adults. American Journal of Gastroenterology.
2025;120(6):1187–224. doi:10.14309/ajg.0000000000003463
137.
Lichtenstein GR, Loftus
EV, Isaacs KL, et al. ACG clinical guideline: Management of
crohn’s disease in adults. American Journal of Gastroenterology.
2025;120(6):1225–64. doi:10.14309/ajg.0000000000003465
138.
Rubio-Tapia A, Hill ID,
Semrad C, et al. American college of gastroenterology guidelines
update: Diagnosis and management of celiac disease. American Journal of
Gastroenterology. 2023;118(1):59–76. doi:10.14309/ajg.0000000000002075
139.
Rome Foundation. Rome IV criteria: Irritable
bowel syndrome [Internet]. 2016 [cited 2026 Aug 4]. Available from: https://theromefoundation.org/rome-iv/rome-iv-criteria/
140.
Japanese Society of Hepato-Biliary-Pancreatic
Surgery. Tokyo guidelines 2018 for the management of acute cholangitis
and cholecystitis [Internet]. 2018 [cited 2026 Aug 4]. Available from:
https://www.jshbps.jp/modules/en/index.php?content_id=47
141.
Buxbaum JL, Abbas Fehmi
SM, Sultan S, et al. ASGE guideline on the role of endoscopy in
the evaluation and management of choledocholithiasis. Gastrointestinal
Endoscopy. 2019;89(6):1075–1105.e15. doi:10.1016/j.gie.2018.10.001
142.
Gomi H, Solomkin JS,
Schlossberg D, et al. Tokyo guidelines 2018: Antimicrobial
therapy for acute cholangitis and cholecystitis. Journal of
Hepato-Biliary-Pancreatic Sciences. 2018;25(1):3–16. doi:10.1002/jhbp.518
143.
Colling KP, Besshoff KE,
Forrester JD, et al. Surgical infection society guidelines for
antibiotic use in patients undergoing cholecystectomy for gallbladder
disease. Surgical Infections. 2022;23(4):339–50. doi:10.1089/sur.2021.207
144.
Nadim MK, Kellum JA, Forni
L, et al. Acute kidney injury in patients with cirrhosis: Acute
disease quality initiative and international club of ascites joint
multidisciplinary consensus meeting. Journal of Hepatology.
2024;81(1):163–83. doi:10.1016/j.jhep.2024.03.031
145.
Lee WM, Stravitz RT, Larson AM. AASLD position
paper: The management of acute liver failure, update 2011 [Internet].
American Association for the Study of Liver Diseases; 2011 [cited 2026
Aug 4]. Available from: https://www.aasld.org/sites/default/files/2019-06/AcuteLiverFailureUpdate2011.pdf
146.
US
Food and Drug Administration. TERLIVAZ (terlipressin) prescribing
information [Internet]. 2022 [cited 2026 Aug 4]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022231s000lbl.pdf
147.
US
Food and Drug Administration. ACETADOTE (acetylcysteine) injection
prescribing information [Internet]. 2024 [cited 2026 Aug 4]. Available
from: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021539
148.
Silva JSV da, Seres DS,
Sabino K, et al. ASPEN consensus recommendations for refeeding
syndrome. Nutrition in Clinical Practice. 2020;35(2):178–95. doi:10.1002/ncp.10474
149.
Ko CW, Siddique SM, Patel
A, et al. AGA clinical practice guidelines on the
gastrointestinal evaluation of iron deficiency anemia. Gastroenterology.
2020;159(3):1085–94. doi:10.1053/j.gastro.2020.06.046
150.
Thomson AD, Cook CCH, Touquet R, Henry JA. The
royal college of physicians report on alcohol: Guidelines for managing
wernicke’s encephalopathy in the accident and emergency department.
Alcohol and Alcoholism. 2002;37(6):513–21. doi:10.1093/alcalc/37.6.513
151.
Devalia V, Hamilton MS, Molloy AM. Guidelines
for the diagnosis and treatment of cobalamin and folate disorders.
British Journal of Haematology. 2014;166(4):496–513. doi:10.1111/bjh.12959
152.
US
National Library of Medicine. DailyMed: Folic acid tablet drug label
[Internet]. 2026 [cited 2026 Aug 4]. Available from: https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=folic%20acid%20tablet
153.
McClain CJ et al.
ACG clinical guideline: Malnutrition and nutritional recommendations in
liver disease. American Journal of Gastroenterology. 2025. doi:10.14309/ajg.0000000000003379
154.
Heidenreich PA, Bozkurt B,
Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management
of heart failure. Journal of the American College of Cardiology.
2022;79(17):e263–421. doi:10.1016/j.jacc.2021.12.012
155.
Isselbacher EM, Preventza
O, Hamilton Black J, et al. 2022 ACC/AHA guideline for the
diagnosis and management of aortic disease. Journal of the American
College of Cardiology. 2022;80(24):e223–393. doi:10.1016/j.jacc.2022.08.004
156.
Gulati M, Levy PD,
Mukherjee D, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR
guideline for the evaluation and diagnosis of chest pain. Journal of the
American College of Cardiology. 2021;78(22):e187–285. doi:10.1016/j.jacc.2021.07.053
157.
Otto CM, Nishimura RA,
Bonow RO, et al. 2020 ACC/AHA guideline for the management of
patients with valvular heart disease. Journal of the American College of
Cardiology. 2021;77(4):e25–197. doi:10.1016/j.jacc.2020.11.018
158.
Joglar JA, Chung MK,
Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS guideline for the
diagnosis and management of atrial fibrillation. Journal of the American
College of Cardiology. 2024;83(1):109–279. doi:10.1016/j.jacc.2023.08.017
159.
Ommen SR, Ho CY, Asif IM,
et al. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR guideline for the
management of hypertrophic cardiomyopathy. Circulation.
2024;149:e1239–311. doi:10.1161/CIR.0000000000001250
160.
Fowler VG, Durack DT,
Selton-Suty C, et al. The 2023 duke-international society for
cardiovascular infectious diseases criteria for infective endocarditis:
Updating the modified duke criteria. Clinical Infectious Diseases.
2023;77(4):518–26. doi:10.1093/cid/ciad271
161.
Baddour LM, Wilson WR,
Bayer AS, et al. Infective endocarditis in adults: Diagnosis,
antimicrobial therapy, and management of complications. Circulation.
2015;132(15):1435–86. doi:10.1161/CIR.0000000000000296
162.
American College of Cardiology. 2025 concise
clinical guidance: An ACC expert consensus statement on the diagnosis
and management of pericarditis. Journal of the American College of
Cardiology. 2025. doi:10.1016/j.jacc.2025.05.023
163.
Virani SS, Newby LK,
Arnold SV, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for
the management of patients with chronic coronary disease. Circulation.
2023;148(9):e9–119. doi:10.1161/CIR.0000000000001168
164.
Gornik HL, Aronow HD,
Goodney PP, et al. 2024
ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS guideline for the
management of lower extremity peripheral artery disease. Journal of the
American College of Cardiology. 2024;83(24):2497–604. doi:10.1016/j.jacc.2024.02.013
165.
Björck M, Earnshaw JJ,
Acosta S, et al. European society for vascular surgery 2020
clinical practice guidelines on the management of acute limb ischaemia.
European Journal of Vascular and Endovascular Surgery.
2020;59(2):173–218. doi:10.1016/j.ejvs.2019.09.006
166.
Neunert C, Terrell DR,
Arnold DM, et al. American society of hematology 2019 guidelines
for immune thrombocytopenia. Blood Advances. 2019;3(23):3829–66. doi:10.1182/bloodadvances.2019000966
167.
Cuker A, Arepally GM,
Chong BH, et al. American society of hematology 2018 guidelines
for management of venous thromboembolism: Heparin-induced
thrombocytopenia. Blood Advances. 2018;2(22):3360–92. doi:10.1182/bloodadvances.2018024489
168.
World Health Organization. Guideline on
haemoglobin cutoffs to define anaemia in individuals and populations
[Internet]. World Health Organization; 2024 [cited 2026 Aug 4].
Available from: https://www.who.int/publications/i/item/9789240088542
169.
Conrad ME. Anemia. In: Clinical methods: The
history, physical, and laboratory examinations [Internet]. Butterworths;
1990 [cited 2026 Aug 4]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK254/
170.
National Institutes of Health Office of Dietary
Supplements. Vitamin B12: Fact sheet for health professionals
[Internet]. 2026 [cited 2026 Aug 4]. Available from: https://ods.od.nih.gov/factsheets/VitaminB12-HealthProfessional/
171.
Snook J, Bhala N, Beales
ILP, et al. British society of gastroenterology guidelines for
the management of iron deficiency anaemia in adults. Gut.
2021;70(11):2030–51. doi:10.1136/gutjnl-2021-325210
172.
National Institute for Health and Care
Excellence. Vitamin B12 deficiency in over 16s: Diagnosis and management
[Internet]. 2024 [cited 2026 Aug 4]. Available from: https://www.nice.org.uk/guidance/ng239
173.
Jager U, Barcellini W,
Broome CM, et al. Diagnosis and treatment of autoimmune hemolytic
anemia in adults: Recommendations from the first international consensus
meeting. Blood Reviews. 2020;41:100648. doi:10.1016/j.blre.2019.100648
174.
National Heart, Lung, and Blood Institute.
Evidence-based management of sickle cell disease: Expert panel report,
2014 [Internet]. National Institutes of Health; 2014 [cited 2026 Aug 4].
Available from: https://www.nhlbi.nih.gov/health-topics/evidence-based-management-sickle-cell-disease
175.
Brandow AM, Carroll CP,
Creary S, et al. American society of hematology 2020 guidelines
for sickle cell disease: Management of acute and chronic pain. Blood
Advances. 2020;4(12):2656–701. doi:10.1182/bloodadvances.2020001851
176.
Zheng XL, Vesely SK,
Cataland SR, et al. ISTH guidelines for treatment of thrombotic
thrombocytopenic purpura. Journal of Thrombosis and Haemostasis.
2020;18(10):2496–502. doi:10.1111/jth.15010
177.
Taylor FB, Toh CH, Hoots
WK, et al. Towards definition, clinical and laboratory criteria,
and a scoring system for disseminated intravascular coagulation.
Thrombosis and Haemostasis. 2001;86(5):1327–30. doi:10.1055/s-0037-1616068
178.
Iba T, Maier CL, Scarlatescu E, Levy JH.
Introducing the new definition and diagnostic criteria of disseminated
intravascular coagulation released by the international society on
thrombosis and haemostasis in 2025. Seminars in Thrombosis and
Hemostasis. 2026;52(1):10–7. doi:10.1055/a-2675-6068
179.
US
National Library of Medicine. DailyMed: Cablivi (caplacizumab-yhdp) drug
label [Internet]. 2026 [cited 2026 Aug 4]. Available from: https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Cablivi
180.
Levi M, Toh CH, Thachil J, Watson HG.
Guidelines for the diagnosis and management of disseminated
intravascular coagulation. British Journal of Haematology.
2009;145(1):24–33. doi:10.1111/j.1365-2141.2009.07600.x
181.
National Institute for Health and Care
Excellence. Venous thromboembolic diseases: Diagnosis, management and
thrombophilia testing [Internet]. 2023 [cited 2026 Aug 4]. Available
from: https://www.nice.org.uk/guidance/ng158
182.
Ortel TL, Neumann I, Ageno
W, et al. American society of hematology 2020 guidelines for
management of venous thromboembolism: Treatment of deep vein thrombosis
and pulmonary embolism. Blood Advances. 2020;4(19):4693–738. doi:10.1182/bloodadvances.2020001830
183.
US
National Library of Medicine. DailyMed: Xarelto (rivaroxaban) drug label
[Internet]. 2026 [cited 2026 Aug 4]. Available from: https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Xarelto
184.
Bates SM, Rajasekhar A,
Middeldorp S, et al. American society of hematology 2018
guidelines for management of venous thromboembolism: Venous
thromboembolism in the context of pregnancy. Blood Advances.
2018;2(22):3317–59. doi:10.1182/bloodadvances.2018024802
185.
US
National Library of Medicine. DailyMed: Lovenox (enoxaparin sodium) drug
label [Internet]. 2026 [cited 2026 Aug 4]. Available from: https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Lovenox
186.
Tomaselli GF, Mahaffey KW,
Cuker A, et al. 2020 ACC expert consensus decision pathway on
management of bleeding in patients on oral anticoagulants. Journal of
the American College of Cardiology. 2020;76(5):594–622. doi:10.1016/j.jacc.2020.04.053
187.
US
National Library of Medicine. DailyMed: Kcentra (prothrombin complex
concentrate [human]) drug label [Internet]. 2026 [cited 2026 Aug 4].
Available from: https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Kcentra
188.
US
National Library of Medicine. DailyMed: Praxbind (idarucizumab) drug
label [Internet]. 2026 [cited 2026 Aug 4]. Available from: https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Praxbind
189.
US
Food and Drug Administration. Update on the safety of andexxa
[Internet]. 2025 [cited 2026 Aug 4]. Available from: https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/update-safety-andexxa
190.
US
National Library of Medicine. DailyMed: Andexxa (coagulation factor xa
[recombinant], inactivated-zhzo) drug label [Internet]. 2026 [cited 2026
Aug 4]. Available from: https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Andexxa
191.
Carson JL, Stanworth SJ,
Guyatt G, et al. Red blood cell transfusion: 2023 AABB
international guidelines. JAMA. 2023;330(19):1892–902. doi:10.1001/jama.2023.12914
192.
Kaufman RM, Djulbegovic B,
Gernsheimer T, et al. Platelet transfusion: A clinical practice
guideline from the AABB. Annals of Internal Medicine.
2015;162(3):205–13. doi:10.7326/M14-1589
193.
Centers for Disease Control and Prevention.
National healthcare safety network biovigilance component: Hemovigilance
module surveillance protocol [Internet]. 2026 [cited 2026 Aug 4].
Available from: https://www.cdc.gov/nhsn/biovigilance/blood-safety/
194.
Dohner H, Wei AH,
Appelbaum FR, et al. Diagnosis and management of AML in adults:
2022 recommendations from an international expert panel on behalf of the
ELN. Blood. 2022;140(12):1345–77. doi:10.1182/blood.2022016867
195.
Hallek M, Cheson BD,
Catovsky D, et al. iwCLL guidelines for diagnosis, indications
for treatment, response assessment, and supportive management of CLL.
Blood. 2018;131(25):2745–60. doi:10.1182/blood-2017-09-806398
196.
Cheson BD, Fisher RI,
Barrington SF, et al. Recommendations for initial evaluation,
staging, and response assessment of hodgkin and non-hodgkin lymphoma:
The lugano classification. Journal of Clinical Oncology.
2014;32(27):3059–68. doi:10.1200/JCO.2013.54.8800
197.
Rajkumar SV, Dimopoulos
MA, Palumbo A, et al. International myeloma working group updated
criteria for the diagnosis of multiple myeloma. Lancet Oncology.
2014;15(12):e538–48. doi:10.1016/S1470-2045(14)70442-5
198.
Rivera MP, Mehta AC, Wahidi MM. Establishing
the diagnosis of lung cancer: Diagnosis and management of lung cancer,
3rd ed: American college of chest physicians evidence-based clinical
practice guidelines. Chest. 2013;143(5 Suppl):e142S–e165S. doi:10.1378/chest.12-2353
199.
Olsen KM, Manouchehr-Pour
S, Donnelly EF, et al. ACR appropriateness criteria:
hemoptysis. Journal of the American College of Radiology.
2020;17:S148–59. doi:10.1016/j.jacr.2020.01.043
200.
Vogel JD, Felder SI, Bhama
AR, et al. The american society of colon and rectal surgeons
clinical practice guidelines for the management of colon cancer.
Diseases of the Colon and Rectum. 2022;65(2):148–77. doi:10.1097/DCR.0000000000002323
201.
Obermannová R, Alsina M,
Cervantes A, et al. Oesophageal cancer: ESMO
clinical practice guideline for diagnosis, treatment and follow-up.
Annals of Oncology. 2022;33(10):992–1004. doi:10.1016/j.annonc.2022.07.003
202.
Conroy T, Pfeiffer P,
Vilgrain V, et al. Pancreatic cancer: ESMO clinical
practice guideline for diagnosis, treatment and follow-up. Annals of
Oncology. 2023;34(11):987–1002. doi:10.1016/j.annonc.2023.08.009
203.
Machicado JD, Sheth SG,
Chalhoub JM, et al. American society for gastrointestinal
endoscopy guideline on the role of endoscopy in the diagnosis and
management of solid pancreatic masses: Summary and recommendations.
Gastrointestinal Endoscopy. 2024;100(5):786–96. doi:10.1016/j.gie.2024.06.002
204.
Campbell SC, Clark PE,
Chang SS, et al. Renal mass and localized renal cancer:
Evaluation, management, and follow-up: AUA guideline: Part
i. Journal of Urology. 2021;206(2):199–208. doi:10.1097/JU.0000000000001911
205.
Krämer A, Bochtler T,
Pauli C, et al. Cancer of unknown primary: ESMO
clinical practice guideline for diagnosis, treatment and follow-up.
Annals of Oncology. 2023;34(3):228–46. doi:10.1016/j.annonc.2022.11.013
206.
Buxbaum JL, Buitrago C,
Lee A, et al. ASGE guideline on the management of
cholangitis. Gastrointestinal Endoscopy. 2021;94(2):207–221.e14. doi:10.1016/j.gie.2020.12.032
207.
Freifeld AG, Bow EJ,
Sepkowitz KA, et al. Clinical practice guideline for the use of
antimicrobial agents in neutropenic patients with cancer: 2010 update by
the infectious diseases society of america. Clinical Infectious
Diseases. 2011;52(4):e56–93. doi:10.1093/cid/cir073
208.
Howard SC, Jones DP, Pui CH. The tumor lysis
syndrome. New England Journal of Medicine. 2011;364(19):1844–54. doi:10.1056/NEJMra0904569
209.
Taplitz RA, Kennedy EB,
Bow EJ, et al. Outpatient management of fever and neutropenia in
adults treated for malignancy: ASCO and IDSA clinical practice guideline
update. Journal of Clinical Oncology. 2018;36(14):1443–53. doi:10.1200/JCO.2017.77.6211
210.
US
National Library of Medicine. DailyMed: Elitek (rasburicase) drug label
[Internet]. 2026 [cited 2026 Aug 4]. Available from: https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Elitek
211.
Centers for Disease Control and Prevention. HIV
testing [Internet]. 2025 [cited 2026 Aug 4]. Available from: https://www.cdc.gov/hiv/testing/
212.
US
Department of Health and Human Services Panel on Antiretroviral
Guidelines for Adults and Adolescents. Guidelines for the use of
antiretroviral agents in adults and adolescents with HIV [Internet].
2026 [cited 2026 Aug 4]. Available from: https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/whats-new
213.
US
Department of Health and Human Services Panel on Guidelines for the
Prevention and Treatment of Opportunistic Infections in Adults and
Adolescents with HIV. Guidelines for the prevention and treatment of
opportunistic infections in adults and adolescents with HIV [Internet].
2026 [cited 2026 Aug 4]. Available from: https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/whats-new
214.
Global Initiative for Asthma. Global strategy
for asthma management and prevention: 2026 update [Internet]. 2026
[cited 2026 Aug 4]. Available from: https://ginasthma.org/2026-gina-strategy-report/
215.
Global Initiative for Chronic Obstructive Lung
Disease. Global strategy for prevention, diagnosis and management of
COPD: 2026 report [Internet]. 2026 [cited 2026 Aug 4]. Available from:
https://goldcopd.org/2026-gold-report-and-pocket-guide/
216.
Metlay JP, Waterer GW,
Long AC, et al. Diagnosis and treatment of adults with
community-acquired pneumonia: An official clinical practice guideline of
the american thoracic society and infectious diseases society of
america. American Journal of Respiratory and Critical Care Medicine.
2019;200(7):e45–67. doi:10.1164/rccm.201908-1581ST
217.
Jones BE, Ramirez JA, Oren
E, et al. Diagnosis and management of community-acquired
pneumonia: An official american thoracic society clinical practice
guideline. American Journal of Respiratory and Critical Care Medicine.
2025. doi:10.1164/rccm.202507-1692ST
218.
Klompas M, Al-Hasan M, Al
Mohajer M, et al. Infectious diseases society of america position
statement: Why IDSA did not endorse the community-acquired pneumonia
guidelines 2025 update. American Journal of Respiratory and Critical
Care Medicine. 2026;212(5):1064–6. doi:10.1093/ajrccm/aamag065
219.
Acute Respiratory Distress Syndrome Network.
Ventilation with lower tidal volumes as compared with traditional tidal
volumes for acute lung injury and the acute respiratory distress
syndrome. New England Journal of Medicine. 2000;342(18):1301–8. doi:10.1056/NEJM200005043421801
220.
Roberts ME, Rahman NM,
Maskell NA, et al. British thoracic society guideline for pleural
disease. Thorax. 2023;78(Suppl 3):s1–42. doi:10.1136/thorax-2022-219784
221.
Shen KR, Bribriesco A,
Crabtree T, et al. The american association for thoracic surgery
consensus guidelines for the management of empyema. Journal of Thoracic
and Cardiovascular Surgery. 2017;153(6):e129–46. doi:10.1016/j.jtcvs.2017.01.030
222.
Saukkonen JJ, Duarte R,
Munsiff SS, et al. Updates on the treatment of drug-susceptible
and drug-resistant tuberculosis: An official ATS/CDC/ERS/IDSA clinical
practice guideline. American Journal of Respiratory and Critical Care
Medicine. 2025;211(1):15–33. doi:10.1164/rccm.202410-2096ST
223.
National Institute for Occupational Safety and
Health. Work-related respiratory diseases [Internet]. 2026 [cited 2026
Aug 4]. Available from: https://www.cdc.gov/niosh/respiratory/about/
224.
Kapur VK, Auckley DH,
Chowdhuri S, et al. Clinical practice guideline for diagnostic
testing for adult obstructive sleep apnea. Journal of Clinical Sleep
Medicine. 2017;13(3):479–504. doi:10.5664/jcsm.6506
225.
Patil SP, Ayappa IA,
Caples SM, et al. Treatment of adult obstructive sleep apnea with
positive airway pressure: An american academy of sleep medicine clinical
practice guideline. Journal of Clinical Sleep Medicine.
2019;15(2):335–43. doi:10.5664/jcsm.7640
226.
American Academy of Dermatology. Clinical
guidelines [Internet]. 2026 [cited 2026 Aug 4]. Available from: https://www.aad.org/member/clinical-quality/guidelines
227.
Stevens DL, Bisno AL,
Chambers HF, et al. Practice guidelines for the diagnosis and
management of skin and soft tissue infections: 2014 update by the
infectious diseases society of america. Clinical Infectious Diseases.
2014;59(2):e10–52. doi:10.1093/cid/ciu444
228.
Heuer R, Paulmann M,
Annecke T, et al. S3 guideline: Diagnosis and treatment of
epidermal necrolysis (stevens–johnson syndrome and toxic epidermal
necrolysis)—part 1: Diagnosis, initial management, and immunomodulating
systemic therapy. Journal der Deutschen Dermatologischen Gesellschaft.
2024;22(10):1448–66. doi:10.1111/ddg.15515
229.
Kardaun SH, Sidoroff A,
Valeyrie-Allanore L, et al. Variability in the clinical pattern
of cutaneous side-effects of drugs with systemic symptoms: Does a DRESS
syndrome really exist? British Journal of Dermatology.
2007;156(3):609–11. doi:10.1111/j.1365-2133.2006.07692.x
230.
Brüggen MC, Walsh S, Ameri
MM, et al. Management of adult patients with drug reaction with
eosinophilia and systemic symptoms: A delphi-based international
consensus. JAMA Dermatology. 2024;160(1):37–44. doi:10.1001/jamadermatol.2023.4450
231.
Davis DMR, Drucker AM,
Alikhan A, et al. Guidelines of care for the management of atopic
dermatitis in adults with topical therapies. Journal of the American
Academy of Dermatology. 2023;89(1):e1–20. doi:10.1016/j.jaad.2022.12.029
232.
Elmets CA, Korman NJ,
Prater EF, et al. Joint AAD–NPF guidelines of care for the
management and treatment of psoriasis with topical therapy and
alternative medicine modalities for psoriasis severity measures. Journal
of the American Academy of Dermatology. 2021;84(2):432–70. doi:10.1016/j.jaad.2020.07.087
233.
Davis DMR, Drucker AM,
Alikhan A, et al. Guidelines of care for the management of atopic
dermatitis in adults with phototherapy and systemic therapies. Journal
of the American Academy of Dermatology. 2024;90(2):e43–56. doi:10.1016/j.jaad.2023.08.102
234.
Menter A, Gelfand JM,
Connor C, et al. Joint american academy of dermatology–national
psoriasis foundation guidelines of care for the management of psoriasis
with systemic nonbiologic therapies. Journal of the American Academy of
Dermatology. 2020;82(6):1445–86. doi:10.1016/j.jaad.2020.02.044
235.
Reynolds RV, Yeung H,
Cheng CE, et al. Guidelines of care for the management of acne
vulgaris. Journal of the American Academy of Dermatology.
2024;90(5):1006.e1–30. doi:10.1016/j.jaad.2023.12.017
236.
Swetter SM, Tsao H,
Bichakjian CK, et al. Guidelines of care for the management of
primary cutaneous melanoma. Journal of the American Academy of
Dermatology. 2019;80(1):208–50. doi:10.1016/j.jaad.2018.08.055
237.
Bichakjian C, Armstrong A,
Baum C, et al. Guidelines of care for the management of basal
cell carcinoma. Journal of the American Academy of Dermatology.
2018;78(3):540–59. doi:10.1016/j.jaad.2017.10.006
238.
Alam M, Armstrong A, Baum
C, et al. Guidelines of care for the management of cutaneous
squamous cell carcinoma. Journal of the American Academy of Dermatology.
2018;78(3):560–78. doi:10.1016/j.jaad.2017.10.007
239.
US
Food and Drug Administration. Drugs@FDA: Aldara (imiquimod) cream
prescribing information [Internet]. 2026 [cited 2026 Aug 4]. Available
from: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020723
240.
Hewett Brumberg EK, Douma
MJ, Alibertis K, et al. 2024 american heart association and
american red cross guidelines for first aid. Circulation.
2024;150(24):e519–79. doi:10.1161/CIR.0000000000001281
241.
Agency for Toxic Substances and Disease
Registry. Medical management guidelines for hydrogen fluoride
[Internet]. [cited 2026 Aug 4]. Available from: https://wwwn.cdc.gov/TSP/MMG/MMGDetails.aspx?mmgid=1142&toxid=250
242.
American Burn Association. Guidelines for burn
patient referral [Internet]. 2022 [cited 2026 Aug 4]. Available from: https://ameriburn.org/resources/burnreferral/